Baxter International Inc. is a global medical technology company providing a broad portfolio of essential healthcare products, including intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, and surgical equipment. These products are used in over 100 countries by hospitals, nursing homes, and patients at home under physician supervision. Following the divestiture of its Kidney Care business (Vantive) and BioPharma Solutions business, the company focuses on three core segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. To simplify operations and better align its supply chain with commercial activities, the company implemented a new operating model.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Jena Local Court, HRA 502248 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Baxter Medical Systems Beteiligungs-GmbH | Persönlich haftende(r) Gesellschafter(in) | Saalfeld/Saale |
| Name | Type | City | Shares (%) |
|---|---|---|---|
HR Europe B.V. | Kommanditist(in) | Amsterdam | — |
Hillrom Holdings Netherlands B.V. | Kommanditist(in) | Amsterdam | — |
Source: German Commercial Register (Handelsregister) Jena Local Court, HRA 502248 (as of 31 October 2026)
| Date | Contract | Value |
|---|---|---|
| 3.9.2026 | Supplier · LMU Klinikum (Klinikum der Ludwig-Maximilians-Universität München) | — |
| 24.7.2026 | Supplier · Helios Kliniken GmbH | — |
| 11.3.2026 | OP-Tische Supplier · EK-UNICO GmbH | — |
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €207,445,649 | €23,630,947 | €160,349,560 | 525 |
| 2023 | €178,086,775 | €11,956,199 | €146,708,544 | — |
| 2022 | €39,388,059 | -€462,686 | €135,479,473 | — |
| 2021 | €163,030,950 | €12,238,517 | €119,608,472 | 484 |
| 2020 | €176,304,824 | €13,626,436 | €126,856,619 | — |
| 2019 | €169,451,166 | €8,763,665 | €157,109,162 | — |
| 2018 | €176,525,764 | €13,234,281 | €115,259,348 | — |
| 2017 | €167,219,974 | €9,649,886 | €135,472,983 | — |
| 2016 | €161,878,951 | €11,582,433 | €126,622,558 | — |
| 2015 | €145,967,667 | -€2,955,039 | €118,330,021 | 564 |
Sign in to download data
Source: German Commercial Register (Handelsregister) Jena Local Court, HRA 502248 (as of 31 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €44,441,736 | 30.5% |
| Material Costs | €97,696,167 | 67.0% |
| Depreciation | €2,467,784 | 1.7% |
| Interest & Similar | €1,142,635 | 0.8% |
